Dr. Kwame Sekou Denianke, MD

  • Richmond, CA
  • Dermatopathology physician
NPI1710039938PAC ID2365549433
Medicare patients, 2024
11
Part D claims, 2024
1,434
Publications
3
Hospital affiliations
1
Industry payments
$232
Practice address
901 Nevin Ave, Richmond, CA 94801
Practice phone
Call (510) 307-1555
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Richmond Medical Center

Richmond, California

See all 3 affiliations

Find Dr. Denianke's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kwame Sekou Denianke is a dermatopathology physician in Richmond, California

Dr. Denianke practices at Richmond Medical Center in Richmond, California.

Dr. Denianke's NPI, 1710039938, was assigned on January 17, 2007. Dr. Denianke graduated from UCSF School of Medicine in 2001. Dr. Denianke holds California license A96920.

NPI and contact details
Medicare PAC ID
2365549433
NPI enumeration date
January 17, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(510) 307-1555
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
51
Medical school graduation
2001

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kwame Sekou Denianke practices at Richmond Medical Center in Richmond, California

Dr. Denianke's primary practice is Richmond Medical Center, at 901 Nevin Ave, Richmond, CA 94801 in Contra Costa County. The practice phone is (510) 307-1555.

  • Richmond Medical Center
    901 Nevin Ave, Richmond, CA 94801 · Contra Costa CountyPhone(510) 307-1555

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Kwame Sekou Denianke is affiliated with 2 sites of care and 1 medical group

Dr. Denianke's primary practice is Richmond Medical Center in Richmond, California. Dr. Denianke is also affiliated with Oakland Medical Center. The medical group on file is The Permanente Medical Group, Inc.

See all 3 affiliations for Dr. Denianke

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Kwame Sekou Denianke's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denianke practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Richmond Medical CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Denianke practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kwame Sekou Denianke is one of 57 dermatopathology physicians in California

Dermatopathology is Dr. Denianke's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Denianke is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Denianke's licenses on file in 5 states: California, District of Columbia, Maryland, Virginia and New York.

Specialties and state licenses

  • Dermatopathology, CaliforniaPrimaryLicense A96920 · 2006 to 2026 · taxonomy 207ND0900X
  • District of Columbia license2013 to 2018
  • Maryland license2013 to 2018
  • Virginia license2013 to 2018
  • New York license2003 to 2007

Clinical focus

Dmand AI lists contact dermatitis among the conditions Dr. Denianke treats.

Dermatopathology physicians near Dr. Denianke

Counts of dermatopathology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kwame Sekou Denianke treated 11 Medicare patients in 2024, average age 67

CMS counts 11 Medicare patients who saw Dr. Denianke in 2024. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Denianke's median patient age at 47, with 64% women.

Medicare patients, 202411
Average age67
Average risk score1.81

Dr. Denianke's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 47

Patient panel by sex, all payers

  • Women64%
  • Men34%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kwame Sekou Denianke wrote 1,434 Medicare Part D claims in 2024

In 2024, Dr. Denianke wrote 1,434 Medicare Part D claims for 467 patients. 81% of them were for generic drugs. CMS names the drug for 1,306 of them, across 31 drugs with 11 or more claims each, at $599,380 in total drug cost. In 2023, CMS named 1,158 claims across 27 drugs.

Part D claims, 20241,434
Drugs named by CMS31
Total drug cost$599,380
Part D patients467

Dr. Denianke's Part D claims by kind of drug, 2024

  • Generic1,155 claims81%
  • Brand-name279 claims19%

Dr. Denianke's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Denianke's Part D claims, 2024

  • Antibiotics2%29 of 1,434 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,1582024: 1,30613%

Drugs named by CMS: 31 in 2024, 27 in 2023.

See all prescribing by Dr. Denianke

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Kwame Sekou Denianke takes part in Medicare

Dr. Denianke accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find dermatopathology physicians like Dr. Denianke by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kwame Sekou Denianke has 3 publications on record

Dmand AI links 3 papers to Dr. Denianke. Dr. Denianke's most frequent co-authors are Morton J. Cowan, MD, Ilona J. Frieden, MD and Thomas Armstrong Hope, MD.

Papers3

Dr. Denianke's most frequent co-authors

Recent publications by Dr. Denianke

See all 3 publications and co-authors

See who Dr. Denianke researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Denianke works with, so you can find a warm path to the right dermatopathology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kwame Sekou Denianke received $232 in industry payments from 2021 to 2023

CMS Open Payments shows 3 general payments to Dr. Denianke from 3 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Stemline Therapeutics Inc. paid the most, $104.

General payments to Dr. Denianke by program year, 2021 to 2023

Companies that paid Dr. Denianke the most, 2021 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Denianke

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kwame Sekou Denianke has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Denianke, most recently AAD Fellow in 2011.

Awards and honors for Dr. Denianke

  1. 2011
    • AAD Fellow
  2. Undated
    • CMS Stage 1 2012

Source: Dmand AI Professional Profile Data

Dr. Kwame Sekou Denianke graduated from UCSF School of Medicine

Dr. Denianke graduated from UCSF School of Medicine in 2001. Dr. Denianke is a member of AAD.

  1. Medical schoolUCSF School of Medicine
  2. Board certified in dermatologyAmerican Board of Dermatology
  3. Board certified in dermatopathologyAmerican Board of Dermatology

Source: Dmand AI Professional Profile Data

Dr. Kwame Sekou Denianke accepts plans from 2 insurance carriers

Dr. Denianke is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • Kaiser Permanente
  • CMS Medicare

Plan types Dr. Denianke accepts, by number of carriers

  1. EPO1
  2. HMO1
  3. Medicare1
  4. POS1

Source: Dmand AI Insurance Network Data

Sources for Dr. Kwame Sekou Denianke's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kwame Sekou Denianke

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kwame Sekou Denianke's NPI number?

Dr. Kwame Sekou Denianke's NPI number is 1710039938. It was assigned on January 17, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Kwame Sekou Denianke?

Dr. Kwame Sekou Denianke is a dermatopathology physician in Richmond, California. The primary specialty in the NPI Registry is Dermatopathology Physician (taxonomy code 207ND0900X).

Where does Dr. Kwame Sekou Denianke practice?

Dr. Denianke practices at 901 Nevin Ave, Richmond, CA 94801. Dr. Denianke's primary practice is Richmond Medical Center in Richmond, California.

What is Dr. Kwame Sekou Denianke's office phone number?

The practice phone on file for Dr. Denianke is (510) 307-1555.

What is Dr. Kwame Sekou Denianke's medical license number?

Dr. Denianke holds California license A96920, one of the licenses on file in 5 states.

Which states has Dr. Kwame Sekou Denianke been licensed in?

Dmand AI has state licenses on file for Dr. Denianke in California (2006 to 2026), District of Columbia (2013 to 2018), Maryland (2013 to 2018), Virginia (2013 to 2018) and New York (2003 to 2007).

Which hospitals is Dr. Kwame Sekou Denianke affiliated with?

Dr. Denianke is affiliated with Oakland Medical Center.

What medical group is Dr. Kwame Sekou Denianke part of?

Dr. Denianke is linked to The Permanente Medical Group, Inc.

Does Dr. Kwame Sekou Denianke accept Medicare?

Yes. CMS lists Dr. Denianke as accepting Medicare assignment.

How many Medicare patients does Dr. Kwame Sekou Denianke see?

CMS counts 11 Medicare patients who saw Dr. Denianke in 2024, with an average age of 67.

Show 8 more questionsShow fewer questions

Is Dr. Kwame Sekou Denianke board certified?

Yes. Dr. Denianke is board certified in dermatology by the American Board of Dermatology.

Where did Dr. Kwame Sekou Denianke go to medical school?

Dr. Denianke graduated from UCSF School of Medicine in 2001.

What drugs does Dr. Kwame Sekou Denianke prescribe most?

In 2024 Medicare Part D data, Dr. Denianke's most prescribed drugs by claims were Clobetasol Propionate, Triamcinolone Acetonide and Ciclopirox.

Has Dr. Kwame Sekou Denianke received payments from drug or device companies?

CMS Open Payments shows $232 in general payments to Dr. Denianke from 3 companies from 2021 to 2023. The largest total came from Stemline Therapeutics Inc.

How long has Dr. Kwame Sekou Denianke been practicing?

Dr. Denianke graduated from medical school in 2001, 25 years ago.

Does Dr. Kwame Sekou Denianke do research?

Dmand AI links 3 publications to Dr. Denianke.

Who does Dr. Kwame Sekou Denianke publish with?

Dr. Denianke's most frequent co-authors are Morton J. Cowan, MD (1 shared paper), Ilona J. Frieden, MD (1 shared paper) and Thomas Armstrong Hope, MD (1 shared paper).

What insurance does Dr. Kwame Sekou Denianke accept?

Dr. Denianke is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to dermatopathology practices?

See dermatopathology physicians in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)